1. The effect of
mastoparan on
phosphatidylcholine hydrolysis was examined in 1321N1 human
astrocytoma cells.
Mastoparan (3-30 microM) caused an accumulation of
diacylglycerol (DG) and phosphatidic acd (PA) accompanied by
choline release in a concentration- and time-dependent manner. 2. In the presence of 2%
n-butanol,
mastoparan (3-100 microM) induced
phosphatidylbutanol (PBut) accumulation in a concentration- and time-dependent manner, suggesting that
mastoparan activates
phospholipase D (
PLD).
Propranolol (30-300 microM), a
phosphatidate phosphohydrolase inhibitor, inhibited DG accumulation induced by
mastoparan, supporting this idea. 3. Depletion of extracellular free
calcium ion did not alter the effect of
mastoparan on
PLD activity. 4. A
protein kinase C (PKC) inhibitor,
calphostin C (1 microM), did not inhibit
mastoparan-induce
PLD activation but the ability of
mastoparan to stimulate
phospholipase D activity was decreased in the PKC down regulated cells. 5.
PLD activity stimulated by
mastoparan was not prevented by pretreatment of the cells with
pertussis toxin (PT) or C3
ADP-ribosyltransferase. Furthermore,
guanine nucleotides did not affect
PLD activity stimulation by
mastoparan in membrane preparations. 6.
Mastoparan stimulated
PLD in several cell lines such as RBL-2H3, RBL-1, HL-60, P388, endothelial cells, as well as 1321N1 human
astrocytoma cells. 7. These results suggest that
mastoparan induces
phosphatidylcholine (PC) hydrolysis by activation of
PLD, not by activation of
phosphatidylcholine-specific phospholipase C (
PC-PLC);
mastoparan-induced
PLD activation is not mediated by
G proteins.